Study Shows Cancer Drug Raises Dopamine Levels in Parkinsonís Patients

Share

(July 22, 2016) - A small Phase 1 clinical trial from the Georgetown University Medical Center suggests that the approved cancer drug Tasigna (nilotinib) can treat both motor and cognitive problems in patients with Parkinson’s disease or Lewy body dementia. Read more…

Click for a printer friendly version

Back to top